Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Base Sequence × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Leukemia 7 Sarcoma 5 Neoplasms 4 Colorectal Neoplasms 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Melanoma 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Myeloid, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Erythroblastic, Acute 2 Head and Neck Neoplasms 2 Congenital Abnormalities 2 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Waldenstrom Macroglobulinemia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Toxoplasmosis 1 Thrombocytosis 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Recurrence 1 Rectal Neoplasms 1 Radiation Injuries 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 133 Dexamethasone 109 Rituximab 71 fludarabine 65 Lenalidomide 61 Cytarabine 59 Gemcitabine 54 fludarabine phosphate 49 Bortezomib 48 pembrolizumab 46 venetoclax 45 Etoposide 44 Paclitaxel 43 Carboplatin 42 Cisplatin 41 pomalidomide 40 Peripheral Blood Stem Cell Transplantation 38 Filgrastim 37 Radiotherapy 35 Bevacizumab 33 Melphalan 31 Busulfan 31 Calcium Dobesilate 30 carfilzomib 28 Cyclosporine 28 Methotrexate 27 Azacitidine 26 Nivolumab 25 Mycophenolic Acid 25 Temozolomide 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡